{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:12:08Z","timestamp":1791234728599,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.atherosclerosis.2022.02.026","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T19:55:12Z","timestamp":1646078112000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study"],"prefix":"10.1016","volume":"346","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3556-9913","authenticated-orcid":false,"given":"Rina","family":"Mauricio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8614-0108","authenticated-orcid":false,"given":"Kavisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sanghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby R.","family":"Ayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-2382","authenticated-orcid":false,"given":"Anand","family":"Rohatgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanpen","family":"Vongpatanasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1242\/jcs.114.5.853","article-title":"The splice variants of vascular endothelial growth factor (VEGF) and their receptors","volume":"114","author":"Robinson","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib4","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1247\/csf.26.25","article-title":"Structure and function of VEGF\/VEGF-receptor system involved in angiogenesis","volume":"26","author":"Shibuya","year":"2001","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/labinvest.3780050","article-title":"Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids","volume":"80","author":"Hornig","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2002.tb04870.x","article-title":"Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders","volume":"979","author":"Luttun","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.amjcard.2009.07.016","article-title":"Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction","volume":"104","author":"Onoue","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12872-018-0894-1","article-title":"Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes","volume":"18","author":"Marks","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/eurheartj\/ehq429","article-title":"Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction","volume":"32","author":"Hochholzer","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0003319710370963","article-title":"Vascular endothelial growth factor, soluble fms-like tyrosine kinase 1, and the severity of coronary artery disease","volume":"62","author":"Kim","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/heart.89.12.1411","article-title":"Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease","volume":"89","author":"Chung","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib15","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1253\/circj.CJ-10-0432","article-title":"Soluble fms-like tyrosine kinase-1 and the progression of carotid intima-media thickness - 24-month follow-up study","volume":"74","author":"Shin","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib16","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjcard.2004.02.058","article-title":"The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health","volume":"93","author":"Victor","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1148\/radiol.13122707","article-title":"Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas heart study","volume":"269","author":"Maroules","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/HYPERTENSIONAHA.116.07876","article-title":"Regional fat distribution and blood pressure level and variability: the Dallas heart study","volume":"68","author":"Yano","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.amjcard.2005.06.073","article-title":"Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study)","volume":"96","author":"Abdullah","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib21","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.116.023005","article-title":"Sex-based differences in cardiometabolic biomarkers","volume":"135","author":"Lew","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib23","series-title":"Use of Soluble Flt-1 and its Fragments in Cardiovascular Conditions","author":"Buechler","year":"2007"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jacc.2004.05.069","article-title":"African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study","volume":"44","author":"Jain","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2011.03.032","article-title":"The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure","volume":"58","author":"Ky","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cardfail.2014.05.013","article-title":"Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis","volume":"20","author":"Vorovich","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/1471-0528.12128","volume":"120","author":"Myatt","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib28","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US preventive services task force recommendation statement","volume":"317","author":"USPST","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib29","doi-asserted-by":"crossref","first-page":"H777","DOI":"10.1152\/ajpheart.00126.2019","article-title":"Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction","volume":"317","author":"Brothers","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/ATVBAHA.120.313133","article-title":"Ethnicity and arterial stiffness","volume":"40","author":"Schutte","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/HYPERTENSIONAHA.111.174557","article-title":"Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period","volume":"58","author":"van Bussel","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.atherosclerosis.2015.02.020","article-title":"Fibrosis-related biomarkers and large and small vessel disease: the Cardiovascular Health Study","volume":"239","author":"Agarwal","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCIMAGING.113.000980","article-title":"Noncalcified coronary plaque volumes in healthy people with a family history of early onset coronary artery disease","volume":"7","author":"Kral","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2022.02.026_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10554-012-0143-0","article-title":"Subclinical coronary atherosclerosis in young adults: prevalence, characteristics, predictors with coronary computed tomography angiography","volume":"28","author":"Jin","year":"2012","journal-title":"Int. J. Cardiovasc. Imag."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib36","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.110.150078","article-title":"Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort","volume":"56","author":"Mongraw-Chaffin","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib38","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses","volume":"156","author":"McDonald","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2017.09.012","article-title":"Preeclampsia and coronary plaque erosion: manifestations of endothelial dysfunction resulting in cardiovascular events in women","volume":"816","author":"de Jager","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib40","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/HYPERTENSIONAHA.116.07907","article-title":"Markers of vascular dysfunction after hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"68","author":"Grand'Maison","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/uog.17367","article-title":"Preclinical atherosclerosis at the time of pre-eclamptic pregnancy and up to 10 years postpartum: systematic review and meta-analysis","volume":"49","author":"Milic","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/376066a0","article-title":"Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium","volume":"376","author":"Fong","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib43","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1681\/ASN.2009010061","article-title":"The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD","volume":"20","author":"Di Marco","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib45","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.2013.339","article-title":"Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease","volume":"85","author":"Matsui","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002115","article-title":"Elevated soluble fms-like tyrosine kinase-1 and placental-like growth factor levels are associated with development and mortality risk in heart failure","volume":"9","author":"Hammadah","year":"2016","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajog.2004.11.038","article-title":"Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia","volume":"193","author":"Powers","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.atherosclerosis.2022.02.026_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043637","article-title":"Angiogenic factors in women ten years after severe very early onset preeclampsia","volume":"7","author":"Gaugler-Senden","year":"2012","journal-title":"PLoS One"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:48:39Z","timestamp":1758156519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915022001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":49,"alternative-id":["S0021915022001095"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.02.026","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}